CBIO financials
Crescent Biopharma (CBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- CBIO revenue was $10.84M in fiscal 2025, net income -$133.45M.
CBIO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $10.84M | – | -$152.63M | -$133.45M | – |
| 2024 | – | – | -$40.04M | -$37.88M | -0.59 |
| 2023 | $10.00K | – | -$39.28M | -$36.90M | -0.58 |
| 2022 | $75.00K | – | -$47.40M | -$46.69M | -0.89 |
| 2021 | $1.16M | – | -$63.45M | -$63.43M | -1.23 |
| 2020 | $10.16M | – | -$51.51M | -$51.03M | -1.12 |